Carcinoma in situ at the bronchial resection margin: a review.

Auteurs : Vallières E, Van Houtte P, Travis WD, Rami-Porta R, Goldstraw P
Jaar : 2011
Journal : J Thorac Oncol
Volume : 6(10)
Pagina's : 1617-23

Postoperative radiotherapy in non-small cell lung cancer.

Auteurs : Roelandts M, Moretti L, Van Houtte P
Jaar : 2011
Journal : Cancer Radiother
Volume : 15(6-7)
Pagina's : 514-7

Radiotherapy of lung cancer: Any room left for elective mediastinal irradiation in 2011?

Auteurs : Van Houtte P, Roelandts M, Mornex F
Jaar : 2011
Journal : Cancer Radiother
Volume : 15(6-7)
Pagina's : 509-13

Therapeutic advances in non-small cell lung cancer.

Auteurs : Vallières E, Peters S, Van Houtte P, Dalal P, Lim E
Jaar : 2011
Journal : Thorax
Volume : 67
Pagina's : 1097-101

Proteomic changes associated with breast cancer progression in the MCF10AT model.

Auteurs : Fumagalli D, Michiels S, Sotiriou C
Jaar : 2011
Journal : Pharmacogenomics
Volume : 12(1)
Pagina's : 9-10

A time series evaluation of the in vivo effect of letrozole on gene expression in breast cancer.

Auteurs : Fumagalli D, Michiels S, Sotiriou C
Jaar : 2011
Journal : Pharmacogenomics
Volume : 12(1)
Pagina's : 10

Gene-expression changes over time in a tamoxifen-treated breast cancer xenograft model.

Auteurs : Fumagalli D, Michiels S, Sotiriou C
Jaar : 2011
Journal : Pharmacogenomics
Volume : 12(1)
Pagina's : 11

CD44+ CD24-/low phenotype and resistance to trastuzumab in HER2-positive breast cancer cell lines.

Auteurs : Fumagalli D, Michiels S, Sotiriou C
Jaar : 2011
Journal : Pharmacogenomics
Volume : 12(1)
Pagina's : 12-3

Genomic Grade Index: An important tool for assessing breast cancer tumor grade and prognosis.

Auteurs : Filho OM, Ignatiadis M, Sotiriou C
Jaar : 2011
Journal : Crit Rev Oncol Hematol
Volume : 77(1)
Pagina's : 20-9

ZNF703 gene amplification at 8p12 specifies luminal B breast cancer.

Auteurs : Sircoulomb F, Nicolas N, Ferrari A, Finetti P, Bekhouche I, Rousselet E, Lonigro A, Adélaïde J, Baudelet E, Esteyriès S, Wicinski J, Audebert S, Charafe-Jauffret E, Jacquemier J, Lopez M, Borg JP, Sotiriou C, Popovici C, Bertucci F, Birnbaum D, Chaffanet M, Ginestier C
Jaar : 2011
Journal : EMBO Mol Med
Volume : 3(3)
Pagina's : 153-66

Genes expressed in specific areas of the human fetal cerebral cortex display distinct patterns of evolution.

Auteurs : Lambert N, Lambot MA, Bilheu A, Albert V, Englert Y, Libert F, Noel JC, Sotiriou C, Holloway AK, Pollard KS, Detours V, Vanderhaeghen P
Jaar : 2011
Journal : PLoS One
Volume : 6(3)
Pagina's : e17753

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.

Auteurs : Dowsett M, Nielsen TO
Jaar : 2011
Journal : J. Natl. Cancer Inst.
Volume : 103(22)
Pagina's : 1656-64

Evaluation of the Infinium Methylation 450K technology.

Auteurs : Dedeurwaerder S, Defrance M, Calonne E, Denis H, Sotiriou C, Fuks F
Jaar : 2011
Journal : Epigenomics
Volume : 3(6)
Pagina's : 771-84

Breast cancer: Should we assess HER2 status by Oncotype DX?

Auteurs : Ignatiadis M, Sotiriou C
Jaar : 2011
Journal : Nat Rev Clin Oncol
Volume : 9(1)
Pagina's : 12-4

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Auteurs : Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D
Jaar : 2011
Journal : J Thorac Oncol
Volume : 6(2)
Pagina's : 244-85

The 12th Annual Conference on Thoracic Oncology].

Auteurs : Sculier JP
Jaar : 2011
Journal : Rev Med Brux
Volume : 32(2)
Pagina's : 114-5

A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase I/II study.

Auteurs : Villanueva C, Awada A, Campone M, Machiels JP, Besse T, Magherini E, Dubin F, Semiond D, Pivot X
Jaar : 2011
Journal : Eur. J. Cancer
Volume : 47(7)
Pagina's : 1037-45

Lapatinib ditosylate: expanding therapeutic options for receptor tyrosine-protein kinase erbB-2-positive breast cancer.

Auteurs : Awada A, Saliba W, Bozovic-Spasojevic I
Jaar : 2011
Journal : Drugs Today (Barc)
Volume : 47(5)
Pagina's : 335-45

Recurrent thyroid cancer: a molecular-based therapeutic breakthrough.

Auteurs : Lalami Y, Awada A
Jaar : 2011
Journal : Curr Opin Oncol
Volume : 23(3)
Pagina's : 235-40

A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancer.

Auteurs : Mayer EL, Baurain JF, Sparano J, Strauss L, Campone M, Fumoleau P, Rugo H, Awada A, Sy O, Llombart-Cussac A
Jaar : 2011
Journal : Clin Cancer Res
Volume : 17(21)
Pagina's : 6897-6904